SCHEMBL17372966

SCHEMBL17372966

Cc1cc2c(C(C)C)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 12/20 0.82
BCL2 P10415 11/20 0.82
AKR1B1 P15121 5/20 0.82
BCL2L1 Q07817 3/20 0.82
KDM4E B2RXH2 2/20 0.82
MEN1 O00255 2/20 0.82
NPC1 O15118 2/20 0.82
USP2 O75604 2/20 0.82
ALDH1A1 P00352 2/20 0.82
LMNA P02545 2/20 0.82
POLB P06746 2/20 0.82
GAA P10253 2/20 0.82
MAPT P10636 2/20 0.82
THRB P10828 2/20 0.82
HPGD P15428 2/20 0.82
ALOX12 P18054 2/20 0.82
MAPK1 P28482 2/20 0.82
BLM P54132 2/20 0.82
KMT2A Q03164 2/20 0.82
SMN1; SMN2 Q16637 2/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gossypol SCHEMBL9738017 0.91 MCL1 (1.00) MCL1BCL2AKR1B1BCL2L1KDM4E
Gossypol SCHEMBL30260519 0.91 MCL1 (1.00) MCL1BCL2AKR1B1BCL2L1KDM4E
Gossypol SCHEMBL3939 0.91 MCL1 (1.00) MCL1BCL2AKR1B1BCL2L1KDM4E
Gossypol SCHEMBL29355719 0.91 MCL1 (1.00) MCL1BCL2AKR1B1BCL2L1KDM4E
Gossypol SCHEMBL29798874 0.91 MCL1 (1.00) MCL1BCL2AKR1B1BCL2L1KDM4E
Gossypol SCHEMBL23014699 0.90 MCL1 (0.97) MCL1BCL2AKR1B1BCL2L1KDM4E
Gossypol SCHEMBL28855396 0.90 MCL1 (0.97) MCL1BCL2AKR1B1BCL2L1KDM4E
Gossypol SCHEMBL27755741 0.90 MCL1 (0.97) MCL1BCL2AKR1B1BCL2L1KDM4E
Gossypol SCHEMBL27542391 0.90 MCL1 (0.97) MCL1BCL2AKR1B1BCL2L1KDM4E
Gossypol SCHEMBL28166062 0.90 MCL1 (0.97) MCL1BCL2AKR1B1BCL2L1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210236582-A1 ANTIMICROBIAL COMPOSITION BASED ON POLYPHENOLS AND POLYSACCHARIDES, METHOD FOR PREPARING THEREOF AND USE OF THE SAME Nearmedic International Limited (CY) 2021-08-05 US claimed
EP-3864102-A1 ADHESIVE COMPOSITION COMPRISING BLOCK COPOLYMER WITH POLYVINYL AROMATIC ENDBLOCK AND POLY(VINYL AROMATIC/BUTADIENE) COPOLYMER BLOCK AND SIS BLOCK COPOLYMER, ARTICLES, AND METHODS 3M Innovative Properties Company (US) 2021-08-18 EP disclosed
US-20210236582-A1 ANTIMICROBIAL COMPOSITION BASED ON POLYPHENOLS AND POLYSACCHARIDES, METHOD FOR PREPARING THEREOF AND USE OF THE SAME Nearmedic International Limited (CY) 2021-08-05 US disclosed
EP-3793358-A1 ANTIMICROBIAL COMPOSITION BASED ON POLYPHENOLS AND POLYSACCHARIDES, METHOD FOR PREPARING THEREOF AND USE OF THE SAME Nearmedic International Limited (CY) 2021-03-24 EP disclosed
US-20200369618-A1 ASYMMETRIC DERIVATIVES OF POLYPHENOLS OF THE DINAPHTHALINE SERIES, PROCESS OF PREPARING AND USE THEREOF Nearmedic International Limited (CY) 2020-11-26 US disclosed
US-20200369618-A1 ASYMMETRIC DERIVATIVES OF POLYPHENOLS OF THE DINAPHTHALINE SERIES, PROCESS OF PREPARING AND USE THEREOF Nearmedic International Limited (CY) 2020-11-26 US disclosed
WO-2015195616-A1 ADHESIVE TAPE BEARING A PRESSURE-SENSITIVE ADHESIVE THAT COMPRISES A POLAR PHENOLIC TACKIFIER 3M INNOVATIVE PROPERTIES COMPANY (US) 2015-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200369618-A1 ASYMMETRIC DERIVATIVES OF POLYPHENOLS OF THE DINAPHTHALINE SERIES, PROCESS OF PREPARING AND USE THEREOF DNM2, DNM1, MAVS MCL1 3671/4885BCL2 3675/4885AKR1B1 1151/4885
US-20210236582-A1 ANTIMICROBIAL COMPOSITION BASED ON POLYPHENOLS AND POLYSACCHARIDES, METHOD FOR PREPARING THEREOF AND USE OF THE SAME MAVS, TLR3, CD14 MCL1 1058/4885BCL2 2284/4885AKR1B1 4304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.